plasmid pires-hmga1 (Addgene inc)
Structured Review
Plasmid Pires Hmga1, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pires+hmga1/expression+plasmid+pires+hmga1/pm30135148-87-7-9
Average 90 stars, based on 1 article reviews
Images
Related Articles
Transfection:Article Title: MicroRNA-214 suppresses growth, migration and invasion through a novel target, high mobility group AT-hook 1, in human cervical and colorectal cancer cells Article Snippet: miRNA-control (no. CN-001000-01-20), miR-214 mimic (no. C-301153-01), siRNA-control (no. D-001220-01-20), siRNA- HMGA1 (no. M-004597-02), antimiR-control (no. IN-002005-01-20 or anti miR-214 (no. IH-301153-02-0005) were obtained from GE Healthcare Dharmacon (Lafayette, CO, USA). .. Transient transfections of the above (with 5 n M of miRNA and antimiR mimics and 50 nM of siRNA mimics) into CaCx and CRC cells were achieved using Lipofectamine RNAiMAX (no. 13778150, Life Technologies) while pcDNA 3.1, pcDNA 3.1- miR-214 , pIRES (vector control), Article Title: miR-214 activates TP53 but suppresses the expression of RELA, CTNNB1, and STAT3 in human cervical and colorectal cancer cells. Article Snippet: Cell Biochem Funct.. 2017;1–8.. High Mobility Group AT‐hook 1 (HMGA1) was identified as a target of miR‐214 in human cervical and colorectal cancers (CaCx and CRC) in a previous study. Control:Article Title: MicroRNA-214 suppresses growth, migration and invasion through a novel target, high mobility group AT-hook 1, in human cervical and colorectal cancer cells Article Snippet: miRNA-control (no. CN-001000-01-20), miR-214 mimic (no. C-301153-01), siRNA-control (no. D-001220-01-20), siRNA- HMGA1 (no. M-004597-02), antimiR-control (no. IN-002005-01-20 or anti miR-214 (no. IH-301153-02-0005) were obtained from GE Healthcare Dharmacon (Lafayette, CO, USA). .. Transient transfections of the above (with 5 n M of miRNA and antimiR mimics and 50 nM of siRNA mimics) into CaCx and CRC cells were achieved using Lipofectamine RNAiMAX (no. 13778150, Life Technologies) while pcDNA 3.1, pcDNA 3.1- miR-214 , pIRES (vector control), Article Title: miR-214 activates TP53 but suppresses the expression of RELA, CTNNB1, and STAT3 in human cervical and colorectal cancer cells. Article Snippet: Cell Biochem Funct.. 2017;1–8.. High Mobility Group AT‐hook 1 (HMGA1) was identified as a target of miR‐214 in human cervical and colorectal cancers (CaCx and CRC) in a previous study. Plasmid Preparation:Article Title: MicroRNA-214 suppresses growth, migration and invasion through a novel target, high mobility group AT-hook 1, in human cervical and colorectal cancer cells Article Snippet: miRNA-control (no. CN-001000-01-20), miR-214 mimic (no. C-301153-01), siRNA-control (no. D-001220-01-20), siRNA- HMGA1 (no. M-004597-02), antimiR-control (no. IN-002005-01-20 or anti miR-214 (no. IH-301153-02-0005) were obtained from GE Healthcare Dharmacon (Lafayette, CO, USA). .. Transient transfections of the above (with 5 n M of miRNA and antimiR mimics and 50 nM of siRNA mimics) into CaCx and CRC cells were achieved using Lipofectamine RNAiMAX (no. 13778150, Life Technologies) while pcDNA 3.1, pcDNA 3.1- miR-214 , pIRES (vector control), Article Title: miR-214 activates TP53 but suppresses the expression of RELA, CTNNB1, and STAT3 in human cervical and colorectal cancer cells. Article Snippet: Cell Biochem Funct.. 2017;1–8.. High Mobility Group AT‐hook 1 (HMGA1) was identified as a target of miR‐214 in human cervical and colorectal cancers (CaCx and CRC) in a previous study. Construct:Article Title: MicroRNA-214 suppresses growth, migration and invasion through a novel target, high mobility group AT-hook 1, in human cervical and colorectal cancer cells Article Snippet: miRNA-control (no. CN-001000-01-20), miR-214 mimic (no. C-301153-01), siRNA-control (no. D-001220-01-20), siRNA- HMGA1 (no. M-004597-02), antimiR-control (no. IN-002005-01-20 or anti miR-214 (no. IH-301153-02-0005) were obtained from GE Healthcare Dharmacon (Lafayette, CO, USA). .. Transient transfections of the above (with 5 n M of miRNA and antimiR mimics and 50 nM of siRNA mimics) into CaCx and CRC cells were achieved using Lipofectamine RNAiMAX (no. 13778150, Life Technologies) while pcDNA 3.1, pcDNA 3.1- miR-214 , pIRES (vector control), Article Title: miR-214 activates TP53 but suppresses the expression of RELA, CTNNB1, and STAT3 in human cervical and colorectal cancer cells. Article Snippet: Cell Biochem Funct.. 2017;1–8.. High Mobility Group AT‐hook 1 (HMGA1) was identified as a target of miR‐214 in human cervical and colorectal cancers (CaCx and CRC) in a previous study. Luciferase:Article Title: miR-214 activates TP53 but suppresses the expression of RELA, CTNNB1, and STAT3 in human cervical and colorectal cancer cells. Article Snippet: Cell Biochem Funct.. 2017;1–8.. High Mobility Group AT‐hook 1 (HMGA1) was identified as a target of miR‐214 in human cervical and colorectal cancers (CaCx and CRC) in a previous study. |
